Form 4: Orthopediatrics Corp Director Marie C Infante Reports Acquisition of 2,766 Shares
SEC Form 4
Director Marie C Infante reports acquiring 2,766 shares of Orthopediatrics Corp common stock on May 28, 2024.
Summary
- On May 28, 2024, Marie C Infante, a director of Orthopediatrics Corp, acquired 2,766 shares of common stock.
- The shares were acquired directly.
- Following the transaction, Infante beneficially owns 11,365 shares of Orthopediatrics Corp, which includes 4,640 restricted stock awards.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. While insider buying can be seen as positive, this is a relatively small transaction.
Positives
- A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in a transaction involving the company's securities. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.
Key Dates
| Date | Description |
|---|---|
| 05/28/2024 | Date of transaction: Marie C Infante acquired 2,766 shares of common stock. |
| 05/30/2024 | Date of signature: Daniel J. Gerritzen, Attorney-in-Fact, signed the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.